Navigation Links
FDA sees nanotech challenges in every product category it regulates

WASHINGTON, DC—According to Project on Emerging Nanotechnologies Director David Rejeski, “Today, FDA took a step forward in fulfilling its responsibilities for nanotechnology oversight. If nanotechnology regulation was a baseball game, FDA has scored the first run in the first inning. But the agency must act rapidly to adopt and fully implement the Nanotechnology Task Force’s recommendations. Without moving quickly and building on the recommendations in the Task Force report, FDA will not be able to keep pace with today’s rapidly developing nanotechnology market or engender consumer and investor confidence in emerging products.”

Just released, this is the first report from the Food and Drug Administration’s Nanotechnology Task Force about the agency’s regulatory approach toward nanotechnology—an exciting new field of engineering and science that is estimated to grow to $2.6 trillion in manufactured goods globally by 2014. As the Task Force report highlights, nanotechnology impacts every area of FDA responsibility—drugs, drug delivery systems, cosmetics, medical devices, and food products. Overall, the agency regulates products that are worth nearly $1.5 trillion annually and that account for almost 25 percent of US consumer spending.

“Today, there are more than 500 manufacturer-identified nanotechnology consumer products being sold. These can be found in an online inventory maintained by the Wilson Center’s Project on Emerging Nanotechnologies (see: www.nanotechproject.org/consumerproducts),” said Rejeski. “The number of listed products has more than doubled in a year. It does not include nanotech consumer products which companies do not identify as such, or the hundreds of nano raw materials, intermediate components, and industrial equipment items currently used by manufacturers.”

“In light of this fast-rising commercialization, FDA needs to make certain that it has the tools,
'"/>

Source:http://www.nanotechproject.org/82


Page: 1 2

Related biology news :

1. Revolutionary nanotechnology illuminates brain cells at work
2. Nanotechnology to provide portable genetic risk detection
3. Scientists develop nanotech-laser treatment that kills cancer cells without harming healthy tissue
4. New, unique microscope for nanotech
5. Nanotechnology may find disease before it starts
6. Nanotechnology being used to improve biocompatibility of human prosthetics and implants
7. Nanotech tools yield DNA transcription breakthrough
8. Silver bullet: UGA researchers use laser, nanotechnology to rapidly detect viruses
9. Nanotechnology propels advances in regenerative medicine research
10. New nanotechnology able to examine single molecules, aiding in determining gene expression
11. Nanotechnology shows promise as next wrinkle fighter

Post Your Comments:
(Date:11/22/2009)...o tobacco smoke and during childhood to lead face ...search done at Cincinnati Children,s Hospital Medi...percent of ADHD cases in children between the ages...of these environmental exposures. This could trans... lead exposure each have their own important adver...
(Date:11/22/2009)...ease the likelihood of immune complications follow...team of researchers reports in the November 22 adv...ene, called UGT2B17, is missing from the donor,s g...have a significantly greater risk of a serious sid...ich immune cells from the donor attack tissues in ...
(Date:11/22/2009)...partnership of the University of British Columbia ...esearch Institute, have uncovered new information ...wing a stroke, as well as a possible way to mitiga...ntly published online in Nature Medicine . , Fo... even after blood flow has been restored. Research...
Breaking Biology News(10 mins):Exposure to lead, tobacco smoke raises risk of ADHD 2Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4New understanding about mechanism for cell death after stroke leads to possible therapy 2LodgeNet Interactive Announces Completion of Offering of 2457 5 Million of Convertible Preferred Stock 50318 1LodgeNet Interactive Announces Completion of Offering of 2457 5 Million of Convertible Preferred Stock 50318 2LodgeNet Interactive Announces Completion of Offering of 2457 5 Million of Convertible Preferred Stock 50318 3LodgeNet Interactive Announces Completion of Offering of 2457 5 Million of Convertible Preferred Stock 50318 4MedImmune Expands Access for Eligible Premature Infants to Receive Synagis 28R 29 at No Cost 50313 1MedImmune Expands Access for Eligible Premature Infants to Receive Synagis 28R 29 at No Cost 50313 2MedImmune Expands Access for Eligible Premature Infants to Receive Synagis 28R 29 at No Cost 50313 3NSF provides 243 4 million to study climatically important Agulhas Current 9052 1NSF provides 243 4 million to study climatically important Agulhas Current 9052 2
... will today for the first time be able to join tog...nes that underlie a range of chronic diseases. , ...er common diseases have been providing blood sampl...ject hosted by The University of Manchester that w...dy genes in chronic diseases. The project - called...
... penetrate living lymph nodes, UCSF scientists hav...helping clarify how T cells control autoimmunity. ...ng microscopy, was able to focus deep within the l...chers to show that immune cells known as T regulat... of rogue autoimmune cells when each of the two ce...
...ove all the oxygen, mix in a bit of poisonous carb...sounds like a recipe for a witch,s brew. It may b...microbe known as Carboxydothermus hydrogenoforman...issue of PLoS Genetics, a research team led by sc...GR) report the determination and analysis of the c...
Other Biology News:'Dating agency' boosts hunt for disease genes 2Scientists directly view immune cells interacting to avert autoimmunity 2Scientists directly view immune cells interacting to avert autoimmunity 3Scientists directly view immune cells interacting to avert autoimmunity 4Poison + water = hydrogen. New microbial genome shows how 2Poison + water = hydrogen. New microbial genome shows how 3
(Date:11/23/2009)...NEVILLAGE,Nev.,Nov.23/PRNewswire-FirstCall/--PDLBi...NASDAQhasestablishedNovember27,2009astheex-dividen...sresultingfromthesecuritizationtransactioncomplete...5,2009toallstockholdersofrecordontherecorddate,Dec...ntofthedividendat$1.67pershareofcommonstockforpurp...
(Date:11/23/2009)...NG,Mich.,Nov.23/PRNewswire-FirstCall/--NeogenCorpo...owder,Ph.D.,waselectedtoNeogen,sBoardofDirectorsat..., Crowderhasmorethan40yearsofexperienceinthefood,...anadjunctprofessorofagriculturaleconomicsatVirgini...edasUnitedStateschiefagriculturenegotiatorwithther...
(Date:11/23/2009)...LE,Nov.23/PRNewswire/--ImmuneDesignC or p.(IDC)ann...cutiveChairman.Dr.Carterhasasuccessfultrackrec or ...erChiefExecutiveOfficeratZymoGenetics,inSeattle,WA...n,Denmark. ,, (Photo: http://www.newscom.com/cg...IDC,sfounderandChiefExecutiveOfficercommented,"Iam...
(Date:11/23/2009)...AINVIEW,Calif.,Nov.23/PRNewswire/--Frost&Sulli...ompaniesfordemonstratingleadershipandinnovationThu...novationAwardsBanquetheldinSanAntonio,Texas. ,,...17/FSLOGO ) ,, TheHealthcareInnovationAwardsare...ontothedeliveryandmanagementofhealthcare.Suchcompa...
Breaking Biology Technology:PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2Richard T. Crowder Joins Neogen's Board of Directors 2Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3
..., WALTHAM, Mass., May 5 Syrinx Consulting Corpo...t firm that delivers easy-to-use .Net and ShareP...igned a contract for approximately $100,000 with a...rea. The engagement includes securely migrating t...rePoint 2003 environment to the Microsoft Office S...
..., New Study Published in the Journal of Rheumatolo...tment Failure Gout Patients , , EAST BRUNSWICK, N... SVNT ) announced today the print publication of...(non-interventional) study of patients with treatm... was to determine the baseline characteristics and...
..., EVRY, France, May 5 Novagali Pharma, a Fren...day that the Company,s,Investigational New Drug Ap...ial of Catioprost(R) (Nova21027), for the treatmen...d Drug Administration (FDA). Catioprost(R) is a,to...atanoprost which,furthermore benefits from the ocu...
Other Biology Technology:Syrinx Wins Contract with Leading Pharmaceutical Company for SharePoint 2007 Services 2Disability and Poor Quality of Life Associated With Treatment Failure Gout Patients 2Disability and Poor Quality of Life Associated With Treatment Failure Gout Patients 3Disability and Poor Quality of Life Associated With Treatment Failure Gout Patients 4Novagali Pharma Announces FDA Clearance of IND for Phase III of Catioprost(R), its Cationic Emulsion of Latanoprost in Patients With Glaucoma 2
Mouse Anti-Human ADP-Ribosylation Factor 1 Monoclonal Antibody, Unconjugated, Clone 3F1 from CHEMICON
Mouse Anti-Human Myeloid Marker Monoclonal Antibody, Unconjugated, Clone BM-1 from Santa Cruz Biotechnology, Inc.
Canine IL-4 ELISpot Kit from R&D Systems
Canine IL-10 ELISpot Kit from R&D Systems
Biology Products: